 As a guest host of Squawkbox on CNBC, BIO President & CEO Jim Greenwood discussed the importance of encouraging innovation in health care reform including a pathway for the approval of biosimilars. Other topics included biofuels and biobased materials.
View CNBC video! |
BIO Announces Presidents Bill Clinton and George W. Bush to Provide Keynote at 2010 BIO International Convention
The Biotechnology Industry Organization (BIO) today announces that Presidents Bill Clinton and George W. Bush, the 42nd and 43rd Presidents of the United States, will appear together for a moderated discussion at the 2010 BIO International Convention, which will be held May 3-6 in Chicago, Ill. at McCormick Place.
Read the news release
Friday, November, 20
U.S. Farmers Continue to Favor Biotech Crop Varieties
American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996 because of the tangible benefits that biotech varieties deliver. According to the U.S. Department of Agriculture, U.S. farmers have embraced biotech varieties of soybeans, cotton and corn at the rate of 91 percent, 88 percent and 85 percent, respectively.
Read the news release
Tuesday, November, 17
BIO Urges Administration and Congressional Leaders to Reject GPhA’s Request to Turn Their Backs on Hope for Patients and Consumers
The Biotechnology Industry Organization (BIO) issued the following statement today in response to a letter recently sent from the Generic Pharmaceutical Association (GPhA) to the White House requesting the Obama Administration urge Congressional leaders to strike biosimilars provisions from health care reform legislation unless the provisions are "materially altered".
Read the news release
Friday, November, 13
|
BIO thanks:
BIO Double Helix Sponsors
BIO Helix Sponsors
|
